Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Subjects With Advanced Tumors

Mise à jour : Il y a 4 ans
Référence : NCT02407990

Femme et Homme

Extrait

This study will evaluate the safety, tolerability, pharmacokinetic profile and treatment effect of a new drug known as BGB-A317 in patients with advanced tumors.


Critère d'inclusion

  • advanced cancer


Liens